603882 金域医学
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.1597.57136.88543.99249.810
总资产报酬率 ROA (%)0.8255.01522.35725.52727.363
投入资产回报率 ROIC (%)1.0596.97533.45238.73631.906

边际利润分析
销售毛利率 (%)35.15436.47843.12847.29246.685
营业利润率 (%)1.9618.89721.62823.25022.039
息税前利润/营业总收入 (%)1.6908.65721.37623.09022.175
净利润/营业总收入 (%)1.4937.45818.38319.79019.086

收益指标分析
经营活动净收益/利润总额(%)522.470122.168106.417101.367100.216
价值变动净收益/利润总额(%)-5.33935.522-0.325-0.266-1.031
营业外收支净额/利润总额(%)-14.874-2.631-0.798-1.063-0.353

偿债能力分析
流动比率 (X)3.2763.0732.3272.1272.060
速动比率 (X)3.1812.9812.2392.0351.957
资产负债率 (%)27.00927.36536.10439.33041.612
带息债务/全部投入资本 (%)7.1174.9664.7477.664--
股东权益/带息债务 (%)1,271.6911,855.2511,940.6821,158.661754.907
股东权益/负债合计 (%)264.120259.693172.122149.086137.082
利息保障倍数 (X)-98.005-701.395-263.228273.356104.148

营运能力分析
应收账款周转天数 (天)251.098260.537135.972110.9230.000
存货周转天数 (天)17.33821.68415.34616.6780.000